PRIME THERAPEUTICS data breach

Clerk's notes

Prime Therapeutics, a company that manages prescription drug benefits, officially reported a data security incident to the Illinois Attorney General on December 22, 2025. This report confirms that the company is investigating unauthorized access to its systems.

The breach indicates that unauthorized parties may have gained access to the personal information of certain individuals. While the specific types of data exposed were not detailed, given Prime Therapeutics' role in healthcare services, they typically maintain sensitive information related to prescription histories and insurance details. If you have received a formal data breach notification letter from Prime Therapeutics, it signifies that your records were likely compromised in this event.

Unauthorized access to your information can create various risks, including potential identity theft or other forms of misuse. It is crucial for recipients of a breach notification to understand the potential impact and take appropriate steps to safeguard their privacy and financial well-being.

As a first step, individuals who received notification letters should carefully review the information provided by Prime Therapeutics. It is generally advisable to remain vigilant for any suspicious activity on your accounts and to monitor explanations of benefits from your health plans.

Understanding your rights after a data security incident is important. If you received a notification from Prime Therapeutics, you may wish to consider requesting a free case review to discuss what this incident could mean for you.

At present, the incident remains under investigation. A case review can help clarify the potential legal avenues available to you without creating an attorney-client relationship or guaranteeing any specific outcome.

If a notification letter about this breach reached you, see every Illinois data breach on file or browse all cases.